UMass Lowell Receives Funding from MLSC to Advance New Continuous Manufacturing Process

This spring UMass Lowell Department of Chemical Engineering, and the UML’s Massachusetts Biomanufacturing Center received funding through the Massachusetts Life Science Center “Building Breakthroughs” program. The funding will support continuous bioprocessing manufacturing as an alternative to batch manufacturing. This new process is being explored in the manufacturing of small molecule drugs by the pharmaceutical industry. event where organizations received funding The research grant is part of a consortium that includes the M2D2 resident company (and 2018 $200K Challenge finalist) Versatope Therapeutics, who have developed an exosome-like vesicle technology currently used for vaccines. With this funding, these organizations are creating a truly transformative “continuous manufacturing” process for biopharmaceutical manufacturing. Continue reading

M2D2 resident company LivOnyx named a 2019 winner in MLSC MassNextGen Initiative

Lt. Gov. Karyn Polito (far left), LivOnyx President/Co-Founder Carmela Mascio (second from left), and MLSC President Travis McCready (third from right) at the MassNextGen winners announcement event on June 19.

We’re thrilled to spread the word that one of our innovative resident companies, LivOnyx, has been named one of five 2019 winners in the Massachusetts Life Sciences Center (MSLC) Massachusetts Next Generation Initiative. LivOnyx will receive $87,500 in funding, as well as access for a year to a network of executive coaches.  

Continue reading